Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction: Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombus-laden lesions

Zeitschrift fur Kardiologie

Volumn 93, Issue 12, 2004, Pages 938-943

  Weber, F ^a   Schneider, H ^a   Schwarz, C ^a   Holzhausen, C ^a   Petzsch, M ^a   Nienaber, C A ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Myocardial infarction; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; METAL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HUMAN; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; REVASCULARIZATION; SAFETY; STENT; THROMBOSIS; THROMBUS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; COATED MATERIALS, BIOCOMPATIBLE; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DEVICE APPROVAL; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 12244276803     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-004-0149-2     Document Type: Article

References (20)

1. Hausleiter J, Kastrati A, Mehilli J et al (2002) Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol 40:882-889
2. Thel MC, Califf RM, Tardiff BE et al (2000) Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IM-PACT-II). Integrilin to minimize platelet aggregation and coronary thrombosis. Am J Cardiol 85:427-434
3. Schuhlen H, Kastrati A, Dirschinger J et al (1998) Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 98:104-111
4. Stone GW, Grines CL, Cox DA et al (2002) A comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346:975-1066
5. Grines CL, Cox DA, Stone GW et al (1999) Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 341:1949-1956
6. Degertekin M, Serruys PW, Foley DP et al (2002) Persistent inhibition of neointimal hyperplasia after sirolimus eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 106:1610-1613
7. Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780
8. Jeanmart H, Malo O, Garner M, Nickner C, Desjardins N, Perrault LP (2002) Comparative study of cyclosporine and tacrolimus vs. newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function. J Heart Lung Transplant 21:990-998
9. Babinska A, Markell MS, Salifu MO, Akoad M, Ehrlich YH, Kornecki E (1998) Enhancement of human platelet aggregation and secretion induced by rapamycin. Nephrol Dial Transplant 13:3153-3159
10. Weyrich AS, Dixon DA, Pabla R et al (1998) Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 95:5556-5561
11. Virmani JR, Farb A, Kolodgie FD (2002) Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences. Herz 27:1-6
12. Teirstein PS (2001) Living the dream of no restenosis. Circulation 104:1996-1998
13. Alpert JS, Thygesen K, Antman E, Bassand JP (2001) Myocardial infarction redefined - a consensus document of The European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959-969
14. Lemos PA, Lee Ch, Degertekin M et al (2003) Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes. J Am Coll Cardiol 41:2093-2099
15. Saia F, Lemos PA, Lee CH et al (2003) Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction. Circulation 108:1927-1931
16. Zahn R, Hamm CW, Zeymer U et al (2004) "Real life" use of sirolimus-eluting stents in Germany: results from the prospective multi-center German Cypher Registry. Z Kardiol 98:287-294
17. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russel ME (2003) TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107:38-42
18. Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. NEJM 349:1315-1323
19. Schofer J, Schluter M, Gershlick AH et al (2003) Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries. Lancet 362:1093-1099
20. Van de Werf F, Ardissino D, Betriu A et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24:28-66